Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fulcrum Pharmaceuticals Inc.

www.fulcrumpharmaceuticals.com

Latest From Fulcrum Pharmaceuticals Inc.

Deal Watch: Lilly Partners With Avidity On RNA Medicines That Can Target Outside The Liver

Privately held Avidity’s platform creates antibody-oligonucleotide conjugate therapies, which build on RNAi approaches. Basilea/Forge collaboration seeks to create novel antibiotics using metalloenzyme chemistry.

Deals Business Strategies

Fulcrum Pharmaceuticals Inc.

Fulcrum Pharmaceuticals Inc. is using its proprietary insights into thermodynamics as a platform technology for rapidly designing thermodynamically optimized lead compounds for drug discovery.
BioPharmaceutical Research and Development Strategies

New Drugs for Osteoporosis

Significant increases in the drug-treated patient population are pushing start-ups to pursue novel mechanisms of action for treating osteoporosis.
BioPharmaceutical

Start-Up Previews (3/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Salve for the Wound Care Market, New Drugs for Osteoporosis and Dermatology Start-Ups. Plus these Start-Ups across Health Care: Avidia Research Institute, Hansen Medical and Vitae Pharmaceuticals.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fulcrum Pharmaceuticals Inc.
  • Senior Management
  • Charles N Blitzer, Pres. & CEO
    Douglas L Gessl, VP, Fin.
  • Contact Info
  • Fulcrum Pharmaceuticals Inc.
    Phone: (919) 226-1440
    2803 Slater Road
    Ste. 125
    Morrisville, NC 27560
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register